Chapter: Stroke and Post-stroke Care

1. Analyze the findings from a standard stroke evaluation and classify a stroke as small vessel, large artery atherosclerotic, cardioembolic, or embolic stroke of unknown source.
2. Apply knowledge of post-stroke pathophysiology to develop a care plan for a patient in the subacute post-stroke period based on treatment guidelines and patient-specific characteristics.
3. Apply knowledge of stroke mechanism and pathophysiology to develop a plan for targeted secondary stroke prevention for a patient in the subacute and chronic post-stroke period based on treatment guidelines and patient-specific characteristics.
4. Develop a short-term and long-term management plan for a patient with embolic stroke of unknown source (ESUS) who may be a candidate for patent foramen ovale closure.
5. Assess for potential sources of embolism in a patient with ESUS and make recommendations for potential treatments for secondary stroke prevention. 

Chapter: Dementias

1. Evaluate a patient with cognitive concerns regarding cognition and other potential causes.
2. Distinguish among the approved classes of medications for dementia and their limitations of use.
3. Design a treatment plan for a patient with dementia throughout the course of the disease process.
4. Develop a treatment approach and goals in the management of chronic disease in a patient with dementia. 

Chapter: Myasthenia Gravis

1. Analyze the clinical and immunopathogenic data to identify phenotypic subgroups of patients with myasthenia gravis (MG).
2. Develop treatment plans for patients with MG on the basis of comorbidities and therapeutic mechanisms of action.
3. Evaluate treatments for MG during family planning and pregnancy. 

Chapter: Seizure Disorders

1. Design a patient-specific antiseizure medication (ASM) regimen and monitoring plan for a patient with newly diagnosed epilepsy and drug-resistant epilepsy.
2. Select appropriate seizure rescue medications for adult patients with epilepsy.
3. Develop and implement safe ASM titrations and tapering in the monitoring unit.
4. Evaluate an ASM regimen based on patient-specific considerations and comorbidities.
5. Construct an education plan on factors that affect quality of life for patients living with epilepsy. 

Chapter: Obesity and Weight Management

1. Classify degrees of adiposity and detect contributors to overweight and obesity.
2. Assess appropriate candidates for weight management interventions on the basis of clinical practice guidelines and recommend appropriate nonpharmacologic and/or pharmacologic interventions.
3. Apply evidence-based treatment principles to make recommendations on short-term weight management medications and supplements.
4. Design safe and effective long-term treatment plans for weight loss on the basis of patientspecific factors. 

Chapter: Sleep Disorders

1. Develop a pharmacotherapy and monitoring plan for a patient with insomnia disorder according to treatment guidelines and patient-specific characteristics.
2. Design a pharmacotherapy and monitoring plan for a patient with restless legs syndrome according to recent guideline updates and patient-specific characteristics.
3. Justify appropriate screening, non-pharmacotherapy, pharmacotherapy, and monitoring plans for a patient with narcolepsy.
4. Evaluate a patient care plan for a patient with obstructive sleep apnea according to guidelines and patient-specific characteristics.
5. Develop a patient care plan for patients with parasomnias or circadian rhythm sleep-wake disorders according to guidelines, available literature, and patient-specific characteristics. 

Case Series: Headache

1. Distinguish the differences between headache types, their diagnosis, and treatment goals.
2. Design a treatment plan for a patient with migraines and apply knowledge of medication overuse headache through a patient’s medication withdrawal.
3. Design a treatment plan for a patient with tension headache.
4. Design a treatment plan for a patient with cluster headache. 

Chapter: Plaque Psoriasis

1. Classify the severity of a patient’s psoriasis using the Psoriasis Area and Severity Index and Physician Global Assessment scales.
2. Develop a pharmacotherapy and monitoring plan for a patient with moderate to severe plaque psoriasis.
3. Assess the impact of comorbidities associated with plaque psoriasis and the resulting impact on drug treatment selection.
4. Evaluate the mechanism of action, efficacy, safety, and adverse effects of biologic agents approved for the use in the treatment of plaque psoriasis.
5. Justify the role of novel and emerging therapies to address unmet needs in the treatment of plaque psoriasis.